Related Experiment Video
Updated: Nov 22, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Cognitive parameters in children with mild obstructive sleep disordered breathing
Jasneek Chawla1,2,3, Margaret-Anne Harris4,5,6, Robert Black4,5,6
1Department of Respiratory & Sleep Medicine, The Queensland Children's Hospital, Level 5a, 501 Stanley Street, South Brisbane, Queensland, 4101, Australia. Jasneek.chawla@health.qld.gov.au.
Insights
Children with sleep disordered breathing (SDB) show similar neurocognitive and behavioral outcomes whether diagnosed with primary snoring (PS) or obstructive sleep apnea (OSA). Symptoms, not just apnea indices, should guide treatment decisions for SDB in children.
Area of Science:
- Pediatric Sleep Medicine
- Neurocognition
- Behavioral Science
Background:
- Sleep disordered breathing (SDB) in children exists on a spectrum from primary snoring (PS) to obstructive sleep apnea (OSA).
- Diagnosis is typically based on apnea indices from polysomnography (PSG).
- This research was registered under ACTRN12611000021976.
Purpose of the Study:
- To evaluate differences in neurocognitive and behavioral parameters in pre-school children with PSG-diagnosed OSA versus PS before treatment.
- To compare symptomatic children with SDB based on PSG findings.
Main Methods:
- Ninety-one symptomatic pre-school children with positive Pediatric Sleep Questionnaire (PSQ) results were enrolled in the POSTA study.
- Neurocognitive and behavioral data were analyzed and compared between PS (Obstructive Apnea-Hypopnea Index < 1/h) and OSA (1-10/h) groups.
- Children were deemed suitable for adenotonsillectomy by an ENT surgeon.
Main Results:
- No significant differences were observed in neurocognitive or behavioral parameters between children diagnosed with OSA and those with PS.
- IQ distribution was slightly skewed towards higher values compared to the reference population.
- Fifty-two children had OSA and 39 had PS.
Conclusions:
- Neurocognitive and behavioral parameters are similar in pre-school children with symptoms of OSA, irrespective of PSG diagnosis of PS or OSA.
- Current treatment approaches often differ despite identical symptoms and outcomes.
- The study suggests considering symptoms and behavioral disturbances alongside the Obstructive Apnea-Hypopnea Index (OAHI) for treatment decisions.
Purpose:
Sleep disordered breathing (SDB) in children is commonly described as a continuum from primary snoring (PS) to obstructive sleep apnea (OSA), based on apnea indices from polysomnography (PSG). This study evaluated the difference in neurocognitive and behavioral parameters, prior to treatment, in symptomatic pre-school children with PSG-diagnosed OSA and PS.
Methods:
All children had positive Pediatric Sleep Questionnaire (PSQ) results and were deemed suitable for adenotonsillectomy by an ENT surgeon. Neurocognitive and behavioral data were analyzed in pre-school children at recruitment for the POSTA study (The Pre-School OSA Tonsillectomy Adenoidectomy Study). Data were compared between PS and OSA groups, with Obstructive Apnea-Hypopnea Index, OAHI < 1/h or 1-10/h, respectively.
Results:
Ninety-one children were enrolled, including 52 with OSA and 39 with PS. Distribution of IQ (using Brief Intellectual Ability, BIA) was slightly skewed towards higher values compared with the reference population. No significant differences were found in neurocognitive or behavioral parameters for children with OSA versus those with PS.
Discussion:
Neurocognitive and behavioral parameters were similar in pre-school children symptomatic for OSA, regardless of whether or not PSG diagnosed PS or OSA. Despite having identical symptoms, children with PS on PSG are often treated conservatively, whereas those with OSA on PSG are considered for adenotonsillectomy. This study demonstrates that, regardless of whether or not PS or OSA is diagnosed on PSG, symptoms, neurocognition, and behavior are identical in these groups. We conclude that symptoms and behavioral disturbances should be considered in addition to OAHI when determining the need for treatment.
Trial Registration:
Australian and New Zealand Clinical Trials registration number ACTRN12611000021976.
More Related Videos
08:20Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
Published on: October 2, 2019
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Respiratory Volumes and Capacities I
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Oppositional Defiant Disorder
Diagnostic Criteria and...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...